Post-Treatment Care: Following your B12 Injection, we provide guidance on post-treatment care
Tendon injuries: Achilles, patellar, rotator cuff, and deltoid tendons, particularly suited to BPC-157 due to tendons' limited blood supply and the peptide's VEGF-driven angiogenic effects Fractures: hairline and stress fractures where bone remodeling and callus formation are the primary repair requirement Muscle strains: sport and exercise-related strains where inflammatory modulation and tissue repair are the goal Wrist and soft tissue injuries: impact injuries and general soft tissue damage Musculoskeletal trauma is one of the most frequent clinical indications for BPC-157
Researchers often report that this is when they notice the first visible changes in problem areas, particularly abdominal fat
To give a subcutaneous injection : Pinch the skin to make a fold
3 RGN-259 Phase 3 Trial in Neurotrophic Keratopathy Sosne et al., International Journal of Molecular Sciences (2022) This Phase 3 randomized, placebo-controlled, double-masked clinical trial evaluated topical 0.1% RGN-259 (full-length recombinant T4 ophthalmic solution) in patients with neurotrophic keratopathy